Boehringer Ingelheim
Brad Smith is an experienced finance professional with a strong background in the animal health sector and corporate finance. Currently serving as the Director, US Animal Health Commercial Business Controller at Boehringer Ingelheim since November 2017, Brad has held multiple leadership positions within the company, including Director of Demand Planning and Associate Director of Livestock Controlling. Prior to this, Brad gained valuable experience at Merial, a Sanofi Company, and Bank of America, where roles included Senior Finance Manager and Vice President. Brad holds an MBA in Finance and Real Estate from The University of Georgia and a BA in Political Science from Furman University.
This person is not in any teams
This person is not in any offices